Abstract
INTRODUCTION. The gradual and long-term development of the pandemic attributed to the SARS-CoV-2 agent has increased the complexity in its expression and the negative effect it has on the collective sphere. The disease reached spaces where human, history and social confluence-imposed scenarios of health and global catastrophe. The baseline risk pattern in Mexico assumed evident characteristics of a vulnerable population, a disease burden with metabolic risk factors and chronic diseases in preponderant sites, as well as unresolved lifestyles and communicable diseases; in a scenario of deteriorated social conditions and a health sector, which facilitated the damage in a damaged space of origin. Objective, analyze the comprehensive bases of the health-disease-care process, linked to COVID-19 and show the potential scenario of collective vulnerability for the recovery period. METHOD. Analytical cross-sectional epidemiological design with critical orientation and theoretical perspective in collective health. RESULTS. Mexico has maintained the highest fatality figures in the world, where 1 in 10 patients die and increase in areas of inaccessibility of health services, with systematically high rates of positivity to the disease and risk of dying from comorbidities and various conditions and modifiable. CONCLUSIONS. The space for the care of the disease and the necessary concurrent recovery of COVID-19 is developed and expected in a scenario with a complex disease burden, deteriorating social conditions and, therefore, a company that requires a reorientation of State policy attending to criteria of primary health care, therefore, beyond the responsibility of health services.
References
Aguado, Guadalupe, G., & Bernaola-Serrano, I. (2020). Verification in the COVID-19 infodemic. Newtral’s case study. Revista Latina de comunicación Social, 2020(78), 289–308. https://doi.org/10.4185/RLCS-2020-1478
Alvis, N., & Valenzuela, M. T. (2010). QALYS and DALYS as synthetic indicators of health. Revista Médica de Chile, 138(SUPPL. 2), 83–87. https://doi.org/10.4067/S0034-98872010001000005
Aquino, Canchari, C. R., Quispe-Arrieta, R. D. C., & Huaman Castillon, K. M. (2020). COVID-19 y su relación con poblaciones vulnerables. Revista Habanera de Ciencias Médicas, 19(Supl.): e3341. http://www.revhabanera.sld.cu/index.php/rhab/article/view/3341
Araujo, González, R. (2015). Vulnerabilidad y riesgo en salud: ¿dos conceptos concomitantes? Vulnerability and health risk: two concomitant concepts? Novedades En Población, 11(21), 89–96. http://www.novpob.uh.cu/index.php/NovPob/article/view/215/248
Barrientos, Gutiérrez, T., Alpuche-Aranda, C., Lazcano-Ponce, E., Pérez-Ferrer, C., & Rivera-Dommarco, J. (2020). La salud pública en la primera ola: una agenda para la cooperación ante COVID-19. Salud Pública De México, 62(5, sep-oct), 598-606. https://doi.org/10.21149/11606
Bello, Chavolla, O. Y., González-Díaz, A., Antonio-Villa, N. E., Fermín-Martínez, C. A., Márquez-Salinas, A., Vargas-Vázquez, A., Bahena-López, J. P., García-Peña, C., Aguilar-Salinas, C. A., & Gutiérrez-Robledo, L. M. (2021). Unequal Impact of Structural Health Determinants and Comorbidity on COVID-19 Severity and Lethality in Older Mexican Adults: Considerations Beyond Chronological Aging. The journals of gerontology. Series A, Biological sciences and medical sciences, 76(3), e52–e59. https://doi.org/10.1093/gerona/glaa163
Campos, R. M. D. (2021). Prevalence and influence of COVID19 in asthma control and lung function in severe asthma patients under biological treatment. J Investig Allergol Clin Immunol, 31(4).
CONACYT - CentroGeo - GeoInt – DataLab. (2021). COVID-19 Tablero México. https://datos.covid-19.conacyt.mx/
CONEVAL. (2021). Pobreza en México. https://www.coneval.org.mx/Medicion/Paginas/PobrezaInicio.aspx
Consejo Nacional de Población [CONAPO]. (2020). La situación demográfica de México 2020, Gobierno de México (n.d.). https://www.gob.mx/conapo/documentos/la-situacion-demografica-de-mexico-2020
COVID-19 Corona Tracker. (2020). Retrieved December 27, 2020, from https://www.coronatracker.com/
Crescioli, G., Brilli, V., Lanzi, C., Burgalassi, A., Ieri, A., Bonaiuti, R., Romano, E., Innocenti, R., Mannaioni, G., Vannacci, A., & Lombardi, N. (2020). Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions. Internal and Emergency Medicine, 1. https://doi.org/10.1007/s11739-020-02586-8
Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., Bonilla-Aldana, D. K., & Rodriguez-Morales, A. J. (2020). Coronavirus disease 2019–COVID-19. Clinical Microbiology Reviews, 33(4), 1–48. https://doi.org/10.1128/CMR.00028-20
Espinosa, Cortés, L. M., Mora Rios, J. M., & Salas Valenzuela, M. (2013). Saberes y trayectorias de atención a la salud de poblaciones vulneradas en México: Un abordaje interdisciplinario. In Saude e Sociedade (Vol. 22, Issue 2, pp. 197–209). Saúde e Sociedade. https://doi.org/10.1590/s0104-12902013000200027
Fajardo, Gutiérrez, A. (2017). Medición en epidemiología: prevalencia, incidencia, riesgo, medidas de impacto. Revista Alergia México, 64(1), 109. https://doi.org/10.29262/ram.v64i1.252
Fernández, Poncela, Anna María. (2012). Psicología de masas, identidad social, epidemias y rumores: la influenza en México. Sociológica (México), 27(76), 189-230. Recuperado en 12 de septiembre de 2021, de http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0187-01732012000200006&lng=es&tlng=es.
Galeano, Eduardo., (1989). El Libro de Los Abrazos.pdf. Retrieved January 16, 2021, from https://docs.google.com/viewer?a=v&pid=sites&srcid=ZGVmYXVsdGRvbWFpbnxnaWxiZXJ0b2dlb3BvbGl0aWNhfGd4OjZhZjUxMDcxZjg5NDk5MjA
Ghazy, R. M., Almaghraby, A., Shaaban, R., Kamal, A., Beshir, H., Moursi, A., Ramadan, A., & Taha, S. H. N. (2020). A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-77748-x
Granda, Edmundo. (2004). A qué llamamos salud colectiva, hoy. Revista Cubana de Salud Pública, 30(2) Recuperado en 12 de septiembre de 2021, de http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662004000200009&lng=es&tlng=es.
Hernández, B., & Velasco-Mondragón, H. E. (2000). Encuestas transversales. In Salud Publica de Mexico (Vol. 42, Issue 5, pp. 447–455). Instituto Nacional de Salud Pública. https://doi.org/10.1590/s0036-36342000000500011
Hong, H., & Kim, H. J. (2020). Antecedents and consequences of information overload in the COVID-19 pandemic. International Journal of Environmental Research and Public Health, 17(24), 1–15. https://doi.org/10.3390/ijerph17249305
Hozhabri, H., Sparascio, F. P., Sohrabi, H., Mousavifar, L., Roy, R., Scribano, D., de Luca, A., Ambrosi, C., & Sarshar, M. (2020). The global emergency of novel coronavirus (SARS-CoV-2): An update of the current status and forecasting. International Journal of Environmental Research and Public Health, 17(16), 1–35. https://doi.org/10.3390/ijerph17165648
Juárez, Ramírez, C., Márquez-Serrano, M., Salgado De Snyder, N., Pelcastre-Villafuerte, B. E., Ruelas-González, M. G., y Reyes-Morales, H. (2014). Temas de actualidad / Current topics La desigualdad en salud de grupos vulnerables de México: adultos mayores, indígenas y migrantes. In Rev Panam Salud Publica, 35 ( 4). Organización Panamericana de la Salud.
Julio, P., & Meier, R. (n.d.). 2 • hechos del callejón. In javeriana.edu.co. Retrieved January 17, 2021, from https://www.javeriana.edu.co/Facultades/Medicina/vidas_moviles/Documentos/victimasdesplazados.pdf
Jung, J., Manley, J., & Shrestha, V. (2020). Coronavirus Infections and Deaths by Poverty Status: The Effects of Social Distancing. Journal of Economic Behavior & Organization. https://doi.org/10.1016/j.jebo.2020.12.019
Lanza, L., Alonso, R., Narváez, S., & Augusto, C. (n.d.). Emergencia, gestión, vulnerabilidad y respuestas frente al impacto de la pandemia COVID-19 en el Perú Emergency, management, vulnerability and responses to the impact the COVID-19 pandemic in Perú. SciELO Preprints. https://doi.org/10.1590/SCIELOPREPRINTS.94
Lazcano, Ponce, E., & Alpuche-Aranda, C. (2020). Alfabetización en salud pública ante la emergencia de la pandemia por COVID-19. Salud Pública De México, 62(3, may-jun), 331-340. https://doi.org/10.21149/11408
Machhi, J., Herskovitz, J., Senan, A. M., Dutta, D., Nath, B., Oleynikov, M. D., Blomberg, W. R., Meigs, D. D., Hasan, M., Patel, M., Kline, P., Chang, R. C. C., Chang, L., Gendelman, H. E., & Kevadiya, B. D. (2020). The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. In Journal of Neuroimmune Pharmacology (Vol. 15, Issue 3, pp. 359–386). Springer. https://doi.org/10.1007/s11481-020-09944-5
Martínez, G. (2021). Seguro De Salud En México, Siguientes Pasos (Health Insurance in Mexico, Next Steps). Siguientes Pasos (Health Insurance in Mexico, Next Steps)(January 31, 2021). http://dx.doi.org/10.2139/ssrn.3777671
Medeiros de Figueiredo, A., Daponte, A., Moreira Marculino de Figueiredo, D. C., Gil-García, E., y Kalache, A. (2020). Case fatality rate of COVID-19: absence of epidemiological pattern. Gaceta Sanitaria. https://doi.org/10.1016/j.gaceta.2020.04.001
Mehrian, Shai, R. (2020). A rational approach to COVID-19. Human Genomics, 14(1). https://doi.org/10.1186/s40246-020-00300-5
Mendez, Dominguez, N., Alvarez-Baeza, A., & Carrillo, G. (2020). Demographic and health indicators in correlation to interstate variability of incidence, confirmation, hospitalization, and lethality in Mexico: Preliminary analysis from imported and community acquired cases during COVID-19 outbreak. International Journal of Environmental Research and Public Health, 17(12), 1–12. https://doi.org/10.3390/ijerph17124281
Mendoza, González, MF., (2021). Rezago social y letalidad en México en el contexto de la pandemia de enfermedad por coronavirus (COVID-19): una aproximación desde la perspectiva de la salud colectiva en los ámbitos nacional, estatal y municipal | Publicación | Comisión Económica para América Latina y el Caribe. (n.d.). Retrieved January 16, 2021, from https://www.cepal.org/es/publicaciones/46558-rezago-social-letalidad-mexico-contexto-la-pandemia-enfermedad-coronavirus-covid
Palacios, Cruz, M., Santos, E., Velázquez Cervantes, M. A., & León Juárez, M. (2020). COVID-19, a worldwide public health emergency. In Revista Clinica Espanola (Vol. 221, Issue 1, pp. 55–61). Elsevier Doyma. https://doi.org/10.1016/j.rce.2020.03.001
Parham, S., Kharazi, A. Z., Bakhsheshi-Rad, H. R., Nur, H., Ismail, A. F., Sharif, S., RamaKrishna, S., & Berto, F. (2020). Antioxidant, Antimicrobial and Antiviral Properties of Herbal Materials. Antioxidants, 9(12), 1309. https://doi.org/10.3390/antiox9121309
Ritchie, H., Mathieu, E., Rodés-Guirao, L., Appel, C., Giattino, C., Ortiz-Ospina, E., Hasell, J., Macdonald, B., Beltekian, D. y Roser, M. (2020). Coronavirus Pandemic (COVID-19). Deaths - Statistics and Research - Our World in Data. OurWorldInData.org. https://ourworldindata.org/covid-deaths
Salinas, Escudero, G., Carrillo-Vega, M. F., Granados-García, V., Martínez-Valverde, S., Toledano-Toledano, F., & Garduño-Espinosa, J. (2020). A survival analysis of COVID-19 in the Mexican population. BMC Public Health, 20(1). https://doi.org/10.1186/s12889-020-09721-2
Stawicki, S., Jeanmonod, R., Miller, A., Paladino, L., Gaieski, D., Yaffee, A., de Wulf, A., Grover, J., Papadimos, T., Bloem, C., Galwankar, S., Chauhan, V., Firstenberg, M., di Somma, S., Jeanmonod, D., Garg, S., Tucci, V., Anderson, H., Fatimah, L., … Garg, M. (2020). The 2019-2020 novel coronavirus (severe acute respiratory syndrome coronavirus 2) pandemic: A joint american college of academic international medicine-world academic council of emergency medicine multidisciplinary COVID-19 working group consensus paper. In Journal of Global Infectious Diseases (Vol. 12, Issue 2, pp. 47–93). Wolters Kluwer Medknow Publications. https://doi.org/10.4103/jgid.jgid_86_20
Suárez, V., Suarez Quezada, M., Oros Ruiz, S., & Ronquillo De Jesús, E. (2020). Epidemiology of COVID-19 in Mexico. Revista Clínica Española (English Edition), 220(8), 463–471. https://doi.org/10.1016/j.rceng.2020.05.008
Won, J.-H., & Lee, H. (2020). The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic. International Journal of Molecular Sciences, 21(24), 9775. https://doi.org/10.3390/ijms21249775
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2021 Mauricio Fidel Mendoza González